Role and Limits of COVID-19 Vaccines in the Delicate Transition from Pandemic Mitigation to Endemic Control

The recent surge of COVID-19 related to the Omicron variant emergence has thrown a harsh light upon epidemic control in the near future. This should lead the scientific and medical community to question the long-term vaccine strategy for SARS-CoV-2 control. We provide here a critical point of view r...

Descripción completa

Detalles Bibliográficos
Autores principales: Mura, Marie, Simon, Fabrice, Pommier de Santi, Vincent, Tangy, Frédéric, Tournier, Jean-Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505741/
https://www.ncbi.nlm.nih.gov/pubmed/36146633
http://dx.doi.org/10.3390/vaccines10091555
_version_ 1784796548718133248
author Mura, Marie
Simon, Fabrice
Pommier de Santi, Vincent
Tangy, Frédéric
Tournier, Jean-Nicolas
author_facet Mura, Marie
Simon, Fabrice
Pommier de Santi, Vincent
Tangy, Frédéric
Tournier, Jean-Nicolas
author_sort Mura, Marie
collection PubMed
description The recent surge of COVID-19 related to the Omicron variant emergence has thrown a harsh light upon epidemic control in the near future. This should lead the scientific and medical community to question the long-term vaccine strategy for SARS-CoV-2 control. We provide here a critical point of view regarding the virological evolution, epidemiological aspects, and immunological drivers for COVID-19 control, including a vaccination strategy. Overall, we need more innovations in vaccine development to reduce the COVID-19 burden long term. The most adequate answer might be better cooperation between universities, biotech and pharmaceutical companies
format Online
Article
Text
id pubmed-9505741
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95057412022-09-24 Role and Limits of COVID-19 Vaccines in the Delicate Transition from Pandemic Mitigation to Endemic Control Mura, Marie Simon, Fabrice Pommier de Santi, Vincent Tangy, Frédéric Tournier, Jean-Nicolas Vaccines (Basel) Review The recent surge of COVID-19 related to the Omicron variant emergence has thrown a harsh light upon epidemic control in the near future. This should lead the scientific and medical community to question the long-term vaccine strategy for SARS-CoV-2 control. We provide here a critical point of view regarding the virological evolution, epidemiological aspects, and immunological drivers for COVID-19 control, including a vaccination strategy. Overall, we need more innovations in vaccine development to reduce the COVID-19 burden long term. The most adequate answer might be better cooperation between universities, biotech and pharmaceutical companies MDPI 2022-09-18 /pmc/articles/PMC9505741/ /pubmed/36146633 http://dx.doi.org/10.3390/vaccines10091555 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Mura, Marie
Simon, Fabrice
Pommier de Santi, Vincent
Tangy, Frédéric
Tournier, Jean-Nicolas
Role and Limits of COVID-19 Vaccines in the Delicate Transition from Pandemic Mitigation to Endemic Control
title Role and Limits of COVID-19 Vaccines in the Delicate Transition from Pandemic Mitigation to Endemic Control
title_full Role and Limits of COVID-19 Vaccines in the Delicate Transition from Pandemic Mitigation to Endemic Control
title_fullStr Role and Limits of COVID-19 Vaccines in the Delicate Transition from Pandemic Mitigation to Endemic Control
title_full_unstemmed Role and Limits of COVID-19 Vaccines in the Delicate Transition from Pandemic Mitigation to Endemic Control
title_short Role and Limits of COVID-19 Vaccines in the Delicate Transition from Pandemic Mitigation to Endemic Control
title_sort role and limits of covid-19 vaccines in the delicate transition from pandemic mitigation to endemic control
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505741/
https://www.ncbi.nlm.nih.gov/pubmed/36146633
http://dx.doi.org/10.3390/vaccines10091555
work_keys_str_mv AT muramarie roleandlimitsofcovid19vaccinesinthedelicatetransitionfrompandemicmitigationtoendemiccontrol
AT simonfabrice roleandlimitsofcovid19vaccinesinthedelicatetransitionfrompandemicmitigationtoendemiccontrol
AT pommierdesantivincent roleandlimitsofcovid19vaccinesinthedelicatetransitionfrompandemicmitigationtoendemiccontrol
AT tangyfrederic roleandlimitsofcovid19vaccinesinthedelicatetransitionfrompandemicmitigationtoendemiccontrol
AT tournierjeannicolas roleandlimitsofcovid19vaccinesinthedelicatetransitionfrompandemicmitigationtoendemiccontrol

Ejemplares similares